Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19

Kory et al., FLCCC Alliance, Dec 2020

Ivermectin for COVID-19

4th treatment shown to reduce risk in August 2020, now with p < 0.0000000001 from 106 studies, recognized in 24 countries.

No treatment is 100% effective.
Protocols combine treatments.

Meta analysis of ivermectin clinical studies and natural experiments where ivermectin has been widely used, showing efficacy of ivermectin in prophylaxis and treatment of COVID-19.
There is potentially inaccurate data collection and/or reporting in some included trials.
7 meta-analyses show significant improvements with ivermectin for mortality1-6, hospitalization7, recovery3, and cases3.
Currently there are 106 ivermectin for COVID-19 studies, showing 47% lower mortality [34‑58%], 35% lower ventilation [17‑50%], 40% lower ICU admission [12‑58%], 34% lower hospitalization [21‑44%], and 79% fewer cases [69‑86%].
OutcomeImprovementEffect · pTreatmentControl
risk of death 69.0% lower · RR 0.31 · p < 0.001*** 69.0% lowerRR 0.31p < 0.001*** 35 of 1,551 (2.3%) 191 of 1,957 (9.8%) treatment 35 of 1,551 (2.3%), control 191 of 1,957 (9.8%)NNT 13odds ratio converted to relative risk

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates. *** p < 0.001

Kory et al., 18 Dec 2020, preprint, 10 authors.